Beetroot Juice for Interstitial Lung Disease
Trial Summary
What is the purpose of this trial?
This trial is testing if drinking beetroot juice with high nitrate levels can help people with a type of lung disease exercise better. The target group is patients with a type of lung disease, who have difficulty breathing and exercising. The nutrients in the beetroot juice help improve blood flow and muscle function, which may make it easier for these patients to exercise. Beetroot juice, rich in nutrients, has been shown to improve exercise performance and muscle efficiency in various populations.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you are using prednisone at more than 10 mg/day for more than two weeks within three months of the first study visit, you may not be eligible to participate.
What data supports the effectiveness of this treatment for Interstitial Lung Disease?
Research shows that beetroot juice, which is high in nitrates, can improve exercise performance and lower blood pressure in patients with chronic obstructive pulmonary disease (COPD). This suggests that beetroot juice might also help people with other lung conditions, like Interstitial Lung Disease, by improving their ability to exercise and reducing blood pressure.12345
Is beetroot juice safe for humans?
How is beetroot juice treatment unique for interstitial lung disease?
Beetroot juice is unique because it contains high levels of dietary nitrate, which can increase plasma nitrate and nitrite levels, potentially improving exercise capacity and reducing blood pressure. This approach is different from standard treatments as it focuses on enhancing physical performance and cardiovascular health through natural dietary supplementation.12458
Research Team
Eligibility Criteria
This trial is for people with certain types of interstitial lung disease (like IPF or NSIP) who have stable oxygen levels and health in the past 6 weeks. They should be able to exercise, not have severe other diseases, no pacemakers or similar devices, and their lung function should be above a specific threshold.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive dietary nitrate supplementation or placebo for 1 week to assess exercise performance
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- concentrated beetroot juice (400mg of nitrate per serving) (Dietary Supplement)
- concentrated beetroot juice (trace amounts of nitrate per serving) (Dietary Supplement)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of British Columbia
Lead Sponsor
Dr. Christopher Haqq
University of British Columbia
Chief Medical Officer since 2019
MD, University of British Columbia
Bekki Bracken Brown
University of British Columbia
Chief Executive Officer since 2023
Bachelor's degree from Duke University